$37.81
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Docebo
DCBONASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Docebo (NASDAQ:DCBO) Stock, Analyst Ratings, Price Targets, Forecasts
Docebo Inc has a consensus price target of $56.89 based on the ratings of 9 analysts. The high is $100 issued by Stifel on December 3, 2021. The low is $44 issued by CIBC on June 21, 2024. The 3 most-recent analyst ratings were released by CIBC, Needham, and Craig-Hallum on June 21, 2024, June 12, 2024, and June 7, 2024, respectively. With an average price target of $49 between CIBC, Needham, and Craig-Hallum, there's an implied 29.60% upside for Docebo Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
CIBC
Needham
Craig-Hallum
Canaccord Genuity
Scotiabank
1calculated from analyst ratings
Analyst Ratings for Docebo
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/21/2024 | Buy Now | 16.37% | CIBC | Stephanie Price | $53 → $44 | Maintains | Outperformer | Get Alert |
| 06/12/2024 | Buy Now | 19.02% | Needham | Ryan MacDonald | $45 → $45 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2024 | Buy Now | 53.4% | Craig-Hallum | George Sutton | → $58 | Initiates | → Buy | Get Alert |
| 05/16/2024 | Buy Now | 19.02% | Needham | Ryan MacDonald | → $45 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 45.46% | Canaccord Genuity | Robert Young | $65 → $55 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | 32.24% | Scotiabank | Kevin Krishnaratne | $65 → $50 | Maintains | Sector Outperform | Get Alert |
| 05/13/2024 | Buy Now | 40.17% | CIBC | Stephanie Price | $58 → $53 | Maintains | Outperformer | Get Alert |
| 05/13/2024 | Buy Now | 56.04% | Morgan Stanley | Josh Baer | $65 → $59 | Maintains | Overweight | Get Alert |
| 05/13/2024 | Buy Now | 26.95% | Goldman Sachs | Kevin Kumar | $55 → $48 | Maintains | Neutral | Get Alert |
| 05/13/2024 | Buy Now | 19.02% | Needham | Ryan MacDonald | $63 → $45 | Maintains | Buy | Get Alert |
| 04/19/2024 | Buy Now | 71.91% | Morgan Stanley | Josh Baer | $67 → $65 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 45.46% | Goldman Sachs | Kevin Kumar | $44 → $55 | Maintains | Neutral | Get Alert |
| 02/26/2024 | Buy Now | 71.91% | Scotiabank | Kevin Krishnaratne | $60 → $65 | Maintains | Sector Outperform | Get Alert |
| 02/26/2024 | Buy Now | 77.2% | Morgan Stanley | Josh Baer | $63 → $67 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | 48.11% | Needham | Ryan MacDonald | → $56 | Initiates | → Buy | Get Alert |
| 11/10/2023 | Buy Now | 16.37% | Goldman Sachs | Kevin Kumar | $39 → $44 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | 40.17% | Morgan Stanley | Josh Jennings | $49 → $53 | Maintains | Overweight | Get Alert |
| 08/18/2023 | Buy Now | 29.6% | Morgan Stanley | Josh Jennings | $40 → $49 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/11/2023 | Buy Now | 5.79% | Morgan Stanley | Josh Jennings | — | Maintains | Equal-Weight | Get Alert |
| 05/22/2023 | Buy Now | -2.14% | Goldman Sachs | Kevin Kumar | → $37 | Initiates | → Neutral | Get Alert |
| 05/12/2023 | Buy Now | -2.14% | Morgan Stanley | Josh Jennings | $39 → $37 | Maintains | Equal-Weight | Get Alert |
| 03/10/2023 | Buy Now | 3.15% | Morgan Stanley | Josh Jennings | $36 → $39 | Maintains | Equal-Weight | Get Alert |
| 03/10/2023 | Buy Now | 32.24% | Canaccord Genuity | Robert Young | $40 → $50 | Maintains | Buy | Get Alert |
| 11/11/2022 | Buy Now | -4.79% | Morgan Stanley | Josh Baer | $40 → $36 | Maintains | Equal-Weight | Get Alert |
| 10/25/2022 | Buy Now | 5.79% | Morgan Stanley | Josh Baer | $44 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/12/2022 | Buy Now | 16.37% | Morgan Stanley | Josh Baer | $41 → $44 | Maintains | Equal-Weight | Get Alert |
| 07/19/2022 | Buy Now | 8.44% | Morgan Stanley | Josh Baer | $43 → $41 | Maintains | Equal-Weight | Get Alert |
| 05/13/2022 | Buy Now | 13.73% | Morgan Stanley | Josh Baer | $54 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/26/2022 | Buy Now | 42.82% | Morgan Stanley | Josh Baer | → $54 | Initiates | → Equal-Weight | Get Alert |
| 12/03/2021 | Buy Now | 164.48% | Stifel | Suthan Sukumar | — | Initiates | → Buy | Get Alert |
| 11/12/2021 | Buy Now | 151.26% | Canaccord Genuity | Robert Young | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Docebo (DCBO) stock?
The latest price target for Docebo (NASDAQ:DCBO) was reported by CIBC on June 21, 2024. The analyst firm set a price target for $44.00 expecting DCBO to rise to within 12 months (a possible 16.37% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Docebo (DCBO)?
The latest analyst rating for Docebo (NASDAQ:DCBO) was provided by CIBC, and Docebo maintained their outperformer rating.
When was the last upgrade for Docebo (DCBO)?
The last upgrade for Docebo Inc happened on August 18, 2023 when Morgan Stanley raised their price target to $49. Morgan Stanley previously had an equal-weight for Docebo Inc.
When was the last downgrade for Docebo (DCBO)?
There is no last downgrade for Docebo.
When is the next analyst rating going to be posted or updated for Docebo (DCBO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Docebo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Docebo was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
Is the Analyst Rating Docebo (DCBO) correct?
While ratings are subjective and will change, the latest Docebo (DCBO) rating was a maintained with a price target of $53.00 to $44.00. The current price Docebo (DCBO) is trading at is $37.81, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.